Tarsus Pharmaceuticals Inc (NAS:TARS)
$ 64.82 -0.66 (-1.01%) Market Cap: 2.84 Bil Enterprise Value: 2.47 Bil PE Ratio: 0 PB Ratio: 8.11 GF Score: 46/100

Q1 2026 Tarsus Pharmaceuticals Inc Earnings Call Transcript

May 6, 2026 / 08:30 PM GMT
Release Date Price: $64.76 (-0.43%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TARS.OQ - Tarsus Pharmaceuticals Inc
Q1 2026 Tarsus Pharmaceuticals Inc Earnings Call
May 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Tarsa's First Quarter 2026 Financial Results Conference Call. As a reminder, this call is being recorded and all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. At this time, I would like to turn the call over to David Nakasone, Head of Administrations, to lead up the call. David, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you. Before we begin, I encourage everyone to visit the Investors section of the Tarsus website to view the earnings release
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot